|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Child Health and Human Development (NICHD) |
| Information provided by: | National Institute of Child Health and Human Development (NICHD) |
| ClinicalTrials.gov Identifier: | NCT00142714 |
Purpose
The long term aims of this project are to 1) Understand the effect of varying degrees and levels of SCI and dysfunction(SCI/D)on females sexual response: 2) Identify the specific neuronal pathways involved in female sexual responses; and 3) Develop and evaluate new assessment and treatment methods for neurogenic sexual dysfunction in women.
| Condition | Intervention |
|
Female Sexual Dysfunction Multiple Sclerosis Spinal Cord Injury |
Procedure: Sympathetic manipulation on sexual arousal in women |
| MedlinePlus related topics: | Multiple Sclerosis Spinal Cord Injuries |
| Study Type: | Interventional |
| Study Design: | Educational/Counseling/Training, Randomized, Open Label, Historical Control, Single Group Assignment |
| Official Title: | Effects of SCI on Female Sexual Response |
| Estimated Enrollment: | 70 |
| Study Start Date: | August 2003 |
| Estimated Study Completion Date: | June 2005 |
Eligibility
| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Paula Spath | 1-866-706-5544 | pspath@uab.edu |
| United States, Alabama | |||||
| The University of Alabama at Birmingham | Recruiting | ||||
| Birmingham, Alabama, United States, 35233 | |||||
| Contact: Paula Spath 205-934-2088 pspath@uab.edu | |||||
| Principal Investigator: Marca Sipski, MD | |||||
| Principal Investigator: | Marca Sipski, MD | The University of Alabama at Birmingham |
More Information
| Study ID Numbers: | 5R01HD030149-09 |
| First Received: | September 1, 2005 |
| Last Updated: | October 13, 2006 |
| ClinicalTrials.gov Identifier: | NCT00142714 |
| Health Authority: | United States: Federal Government |
|
|
|
|